Most of the validated genes, such as IL15 [50], ITGAM [51], PDK4 [52, 53], and IRX5 [54], have been implicated in AML progression and/or as survival predictors in several types of cancers. This evidence concerns the gene IL15 and acute myeloid leukemia.